Fortress Biotech, Inc. - Mar 31, 2025 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role
10%+ Owner
Signature
/s/ Samuel Berry, Attorney-in-Fact
Stock symbol
ATXI
Transactions as of
Mar 31, 2025
Transactions value $
$0
Form type
4
Date filed
4/2/2025, 04:05 PM
Previous filing
Feb 27, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATXI COMMON STOCK, PAR VALUE $0.0001 Award $0 +33.7K +11.44% $0.00 329K Mar 31, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. These shares were granted by the Issuer to the Reporting Person following the receipt of proceeds by the Issuer upon the exercise of warrants previously issued by the Issuer.